Identification of risk factors for requiring transfusion during front-line chemotherapy for ovarian cancer Academic Article uri icon

Overview

MeSH Major

  • Anemia
  • Antineoplastic Combined Chemotherapy Protocols
  • Erythrocyte Transfusion
  • Ovarian Neoplasms

abstract

  • Ovarian cancer patients frequently require RBC transfusion during postdebulking platinum-paclitaxel chemotherapy. Patients with prechemotherapy hemoglobin <10 g/dL and those receiving carboplatin-paclitaxel are at increased risk of requiring RBC transfusion. Early initiation of erythropoietin use in such patients may reduce transfusion needs.

publication date

  • June 11, 2001

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1006/gyno.2001.6185

PubMed ID

  • 11371143

Additional Document Info

start page

  • 485

end page

  • 9

volume

  • 81

number

  • 3